Haroun Gajraj: Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, shared a post on LinkedIn:
“Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
That’s not a rare complication.
That’s one in three.
In fact if it occurs in 30% is it really a complication?
Is it a side effect?
Is it an expectation?
For a procedure patients choose to improve their appearance, post-sclerotherapy hyperpigmentation can be more distressing than the original spider veins – and more damaging to your patient relationship.
But can it be mitigated by the consultation process?
The question isn’t whether it happens in your practice.
It’s whether you know WHY it happens – and What to do about it.”
Other posts featuring Haroun Gajraj on Hemostasis Today.
-
Jul 6, 2026, 04:36Sarah Richardson: On Capitol Hill, Speaking Up for Patients
-
Jul 5, 2026, 23:26Nominations Now Open for the First Nations Stroke Excellence Award – Stroke Foundation
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation